Skip to content

Clinical trials

COVID-19 trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Country / region: Japan Clear all

73 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
202023
202121
202212
20236
20244
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49
Recruiting8
Terminated7
Unknown status6
No longer available1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer10
AstraZeneca8
ModernaTX, Inc.6
Shionogi5
AnGes, Inc.4
Gilead Sciences4
National Institute of Allergy and Infectious Diseases (NIAID)4
Merck Sharp & Dohme LLC3
Takeda3
Genova Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1973
Coronavirus Infections9
Virus Diseases7
Influenza, Human5
Lung Diseases4
Pneumonia4
Respiratory Tract Infections4
Severe Acute Respiratory Syndrome4
Infections3
Pneumonia, Viral3

Trials

Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.